The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre
Abstract
Exposure of young adult C57BL/6 mice to cuprizone in the diet initiated profound and synchronous demyelination of the corpus callosum, which was virtually complete by 4 weeks of exposure. Interestingly, even in the face of a continued exposure to cuprizone, there was spontaneous remyelination 2 weeks later. This remyelination preferentially involved smaller calibre axons. There was a suggestion of yet another cycle of demyelination (at 10 weeks) and remyelination (at 12 weeks), but by 16 weeks of exposure, the regenerative capacity was exhausted and the animals were near death. The relapsing–remitting pattern suggests this may be a useful model for certain human demyelinating disorders. In contrast to the above chronic model, the corpus callosum from mice exposed to cuprizone for only 6 weeks continued to remyelinate, with 67% of the axons being myelinated or remyelinated at 10 weeks. Interestingly, a significant reduction in the mean value for axonal diameter was observed during acute demyelination. Upon remyelination, however, the axonal calibre distribution returned to near‐normal. In contrast, when mice were maintained on a cuprizone diet for 16 weeks, the mean value for axonal diameter was reduced to 60% of normal. These results provide further evidence that the interactions between oligodendrocytes and axons alter axonal calibre.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the continuous exposure of C57BL/6 mice to cuprizone results in a pattern of two cycles of demyelination and remyelination, followed by chronic demyelination from which animals do not recover 36, 39.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [36]
In the citing paper
“Thus, unlike male C57BL/6 mice, which show three cycles of demyelination while on continuous exposure to cuprizone over 13 weeks (36), SJL mice appear to demyelinate gradually once during these time points; however, the demyelination is incomplete.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [36]
In the citing paper
“Previous studies have shown that LFB–PAS scores are reflective to the trends in demyelination when compared with percent myelinated fibers that are counted in electron micrographs 29, 36.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [36]
In the citing paper
“In addition, C57BL/6 mice experience a spontaneous partial remyelination after 6 weeks and then continue to demyelinate further when exposed continuously to cuprizone 36, 39.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [36]
In the citing paper
“Indeed, long-term feeding of cuprizone induces an episodic sequence of demyelinating and remyelinating events, which becomes ineffective over time, progressing to a chronic state of demyelination [26].”
From How to Use the Cuprizone Model to Study De- and Remyelination (2024) · cites this paper as [26]
In the citing paper
“Mason and colleagues rarely observed necrotic axons but showed a mean decrease in axonal caliber, indicating some kind of axonal injury or dysfunction that might impair remyelination [26].”
From How to Use the Cuprizone Model to Study De- and Remyelination (2024) · cites this paper as [26]
Citations
Cites
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P., Koopman, W. J., Hader, W. J., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,169
de Waegh, S. M., Lee, V. M. ‐., & Brady, S. T. (1992) · Cell · doi:10.1016/0092-8674(92)90183-d · Cited by 743
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624
Self-citationWolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
Endogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544
ATLAS OF THE MOUSE BRAIN AND SPINAL CORD
Strich, S. J. (1972) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.35.3.422-b · Cited by 538
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P.-Y., Suzuki, K., & Matsushima, G. K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00168-4 · Cited by 412
Self-citation(1978) · PubMed · Cited by 297
Nixon, R. A., Paskevich, P. A., Sihag, R. K., & Thayer, C. Y. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.4.1031 · Cited by 277
Research works printed but not linked: 2
- Ludwin SK., 1978, Central nervous system demyelination and remyelination in the mouse, Lab Invest, 39, 597
- Ludwin SK., 1980, Chronic demyelination inhibits remyelination in the central nervous system, Lab Invest, 43, 382
Cited by
Sorted by citations
Demyelination increases radial diffusivity in corpus callosum of mouse brain
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.028 · Cited by 1,658
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
White matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0515-3 · Cited by 723
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
Self-citationShen, S., Sandoval, J., Swiss, V. A., Li, J., Dupree, J. L., Franklin, R. J. M., & Casaccia‐Bonnefil, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2172 · Cited by 499
Sun, S., Liang, H., Trinkaus, K., Cross, A. H., Armstrong, R. C., & Song, S. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20774 · Cited by 461
The life, death, and replacement of oligodendrocytes in the adult CNS
McTigue, D. M., & Tripathi, R. B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05570.x · Cited by 474
Chomiak, T., & Hu, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007754 · Cited by 465
Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.004 · Cited by 435
Remyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411
A functional role for EGFR signaling in myelination and remyelination
Aguirre, A. A., Dupree, J. L., Mangin, J., & Gallo, V. (2007) · Nature Neuroscience · doi:10.1038/nn1938 · Cited by 352
Cortical Demyelination Is Prominent in the Murine Cuprizone Model and Is Strain-Dependent
Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070850 · Cited by 271
The Transcription Factor Yin Yang 1 Is Essential for Oligodendrocyte Progenitor Differentiation
He, Y., Dupree, J. L., Wang, J., Sandoval, J., Li, J., Liu, H., Shi, Y., Nave, K. A., & Casaccia‐Bonnefil, P. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.029 · Cited by 272
Sulfatide is essential for the maintenance of CNS myelin and axon structure
Marcus, J., Honigbaum, S., Shroff, S., Honke, K., D, J. R. M., & Dupree, J. L. (2005) · Glia · doi:10.1002/glia.20292 · Cited by 250
Cells of the oligodendroglial lineage, myelination, and remyelination
Miron, V. E., Kuhlmann, T., & Antel, J. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.010 · Cited by 249
White Matter Plasticity and Enhanced Remyelination in the Maternal CNS
Gregg, C., Shikar, V., Larsen, P. H., Mak, G. K., Chojnacki, A. K., Yong, V. W., & Weiss, S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4441-06.2007 · Cited by 234
Quantifying the early stages of remyelination following cuprizone-induced demyelination
Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., & Franklin, R. J. M. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00032.x · Cited by 224
Skripuletz, T., Gudi, V., Hackstette, D., & Stangel, M. (2011) · PubMed · doi:10.14670/hh-26.1585 · Cited by 220
Mason, J. L., Toews, A., Hostettler, J. D., Morell, P., Suzuki, K., Goldman, J. E., & Matsushima, G. K. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63726-1 · Cited by 212
Self-citationBehavioral deficits in the cuprizone-induced murine model of demyelination/remyelination
Franco-Pons, N., Torrente, M., Colomina, M. T., & Vilella, E. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.01.010 · Cited by 195
Ács, P., Kipp, M., Norkutė, A., Johann, S., Clarner, T., Braun, A., Berente, Z., Komoly, S., & Beyer, C. (2008) · Glia · doi:10.1002/glia.20806 · Cited by 194
Jelescu, I. O., Zurek, M., Winters, K. V., Veraart, J., Rajaratnam, A., Kim, N. S., Babb, J. S., Shepherd, T. M., Novikov, D. S., Kim, S. G., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.004 · Cited by 188
Armstrong, R. C., Le, T. Q., Frost, E. E., Borke, R. C., & Vana, A. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08574.2002 · Cited by 178
Mason, J. L., Xuan, S., Dragatsis, I., Efstratiadis, A., & Goldman, J. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07710.2003 · Cited by 177
Self-citationXie, M., Tobin, J. E., Budde, M. D., Chen, C.-I., Trinkaus, K., Cross, A. H., McDaniel, D. P., Song, S.-K., & Armstrong, R. C. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e3de90 · Cited by 175
Lindner, M., Heine, S., Haastert, K., Garde, N., Fokuhl, J., Linsmeier, F., Grothe, C., Baumgärtner, W., & Stangel, M. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00879.x · Cited by 169
LIEBETANZ, D., & MERKLER, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.032 · Cited by 166
Bowley, M. P., Cabral, H., Rosene, D. L., & Peters, A. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22379 · Cited by 162
“Studies of cuprizone-induced demyelination in mice have found that the spontaneous remyelination of demyelinated lesions preferentially involves axons that are less than 1 lm in diameter (Mason et al., 2001).”
BackgroundMcMahon, E. J., Suzuki, K., & Matsushima, G. K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00205-9 · Cited by 161
Self-citationLevels of BDNF Impact Oligodendrocyte Lineage Cells following a Cuprizone Lesion
VonDran, M. W., Singh, H., Honeywell, J. Z., & Dreyfus, C. F. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6595-10.2011 · Cited by 144
Zhang, Y., Zhang, H., Wang, L., Jiang, W., Xu, H., Xiao, L., Bi, X., Wang, J., Zhu, S., Zhang, R., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.04.006 · Cited by 139
Lindner, M., Fokuhl, J., Linsmeier, F., Trebst, C., & Stangel, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.004 · Cited by 136
Lee, H., Yaros, K., Veraart, J., Pathan, J. L., Liang, F., Kim, S., Novikov, D. S., & Fieremans, E. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01844-6 · Cited by 127
Endogenous cell repair of chronic demyelination
Armstrong, R. C., Le, T. Q., Flint, N. C., Vana, A. C., & Zhou, Y.-X. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000205142.08716.7e · Cited by 125
Measles and rubella elimination in the WHO Region for Europe: progress and challenges
O’Connor, P. M., Jankovic, D., Muscat, M., Mamou, M. C. B., Reef, S. E., Papania, M. J., Singh, S., Kaloumenos, T., Butler, R., & Datta, S. S. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.003 · Cited by 123
Taylor, L. C., Gilmore, W., Ting, J. P. ‐., & Matsushima, G. K. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22215 · Cited by 123
Self-citationClemente, D., Ortega, M. C., Melero‐Jerez, C., & de Castro, F. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00268 · Cited by 131
Fletcher, J. L., Murray, S. S., & Xiao, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124131 · Cited by 128
Inflammation in multiple sclerosis: consequences for remyelination and disease progression
Klotz, L., Antel, J. P., & Kuhlmann, T. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00801-6 · Cited by 125
Irvine, K.-A., & Blakemore, W. F. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.002 · Cited by 117
Papadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Merrill, J. E., Hanak, S. E., Pu, S.-F., Liang, J., Dang, C., Iglesias-Bregna, D., Harvey, B., Zhu, B., & McMonagle-Strucko, K. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0075-3 · Cited by 113
Hibbits, N., Pannu, R., Wu, T. J., & Armstrong, R. C. (2009) · ASN Neuro · doi:10.1042/an20090032 · Cited by 111
Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis
Kipp, M., & Beyer, C. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.004 · Cited by 116
Late motor decline after accomplished remyelination: Impact for progressive multiple sclerosis
Manrique‐Hoyos, N., Jürgens, T., Grønborg, M., Kreutzfeldt, M., Schedensack, M., Kuhlmann, T., Schrick, C., Brück, W., Urlaub, H., Simons, M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22681 · Cited by 107
Jurevics, H., Largent, C., Hostettler, J., Sammond, D. W., K. Matsushima, G., Amber Kleindienst, Toews, A. D., & Morell, P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00954.x · Cited by 106
Self-citationMulticontrast MRI of remyelination in the central nervous system
Merkler, D., Boretius, S., Stadelmann, C., Ernsting, T., Michaelis, T., Frahm, J., & Brück, W. (2005) · NMR in Biomedicine · doi:10.1002/nbm.972 · Cited by 102
Platelet-Derived Growth Factor Promotes Repair of Chronically Demyelinated White Matter
Vana, A. C., Flint, N. C., Harwood, N. E., Le, T. Q., Fruttiger, M., & Armstrong, R. C. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181587d46 · Cited by 101
Falangola, M. F., Guilfoyle, D. N., Tabesh, A., Hui, E. S., Nie, X., Jensen, J. H., Gerum, S. V., Hu, C., LaFrancois, J., Collins, H. R., et al. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3140 · Cited by 96
Sullivan, G. M., Mierzwa, A. J., Kijpaisalratana, N., Tang, H., Wang, Y., Song, S., Selwyn, R. G., & Armstrong, R. C. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000009 · Cited by 99
Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice
Hoffmann, K., Lindner, M., Gröticke, I., Stangel, M., & Löscher, W. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.005 · Cited by 93
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains
Kelm, N. D., West, K. L., Carson, R. P., Gochberg, D. F., Ess, K. C., & Does, M. D. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.09.028 · Cited by 84
Marriott, M. P., Emery, B., Cate, H. S., Binder, M. D., Kemper, D., Wu, Q., Kolbe, S., Gordon, I. R., Wang, H., Egan, G., et al. (2008) · Glia · doi:10.1002/glia.20646 · Cited by 86
Taylor, L. C., Gilmore, W., & Matsushima, G. K. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00230.x · Cited by 84
Self-citationWu, Q., Yang, Q., Cate, H. S., Kemper, D., Binder, M. D., Wang, H., Fang, K., Quick, M. J., Marriott, M. P., Kilpatrick, T. J., et al. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21111 · Cited by 86
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model
Tagge, I., O’Connor, A., Chaudhary, P., Pollaro, J., Berlow, Y., Chalupsky, M., Bourdette, D., Woltjer, R., Johnson, M., & Rooney, W. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152480 · Cited by 81
McMahon, E. J., Cook, D. N., Suzuki, K., & Matsushima, G. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2964 · Cited by 75
Self-citationCate, H. S., Sabo, J. K., Merlo, D., Kemper, D., Aumann, T. D., Robinson, J., Merson, T. D., Emery, B., Perreau, V. M., & Kilpatrick, T. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06660.x · Cited by 76
Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination
Hoyos, H. C., Rinaldi, M., Méndez‐Huergo, S. P., Marder, M., Rabinovich, G. A., Pasquini, J. M., & Pasquini, L. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.023 · Cited by 79
GAS6 Enhances Repair Following Cuprizone-Induced Demyelination
Tsiperson, V., Li, X., Schwartz, G. J., Raine, C. S., & Shafit‐Zagardo, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015748 · Cited by 71
Dupree, J. L., Mason, J. L., Marcus, J., Stull, M., Levinson, R., Matsushima, G. K., & Popko, B. (2004) · Neuron Glia Biology · doi:10.1017/s1740925x04000304 · Cited by 75
Self-citationTsiperson, V., Huang, Y., Bagayogo, I. P., Song, Y. J., VonDran, M. W., DiCicco-Bloom, E. M., & Dreyfus, C. F. (2015) · ASN NEURO · doi:10.1177/1759091414566878 · Cited by 66
Ma, J., Tanaka, K. F., Shimizu, T., Bernard, C. C. A., Kakita, A., Takahashi, H., Pfeiffer, S. E., & Ikenaka, K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22567 · Cited by 69
A mouse model for testing remyelinating therapies
Bai, C. B., Sun, H. S., Roholt, A., Benson, E. K., Edberg, D. D., Medicetty, S., Dutta, R., Kidd, G. J., Macklin, W. B., & Trapp, B. D. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.033 · Cited by 68
Axl−/− mice have delayed recovery and prolonged axonal damage following cuprizone toxicity
Hoehn, H. J., Kress, Y., Sohn, A. S. W., Brosnan, C. F., Bourdon, S., & Shafit‐Zagardo, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.076 · Cited by 64
Modeling multiple sclerosis in laboratory animals
Schreiner, B., Heppner, F. L., & Becher, B. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0181-4 · Cited by 63
17β-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss
Taylor, L. C., Puranam, K. L., Gilmore, W., Ting, J. P. ‐., & Matsushima, G. K. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.016 · Cited by 60
Self-citationSághy, É., Sipos, É., Ács, P., Bölcskei, K., Pohóczky, K., Kemény, Á., Zoltán, S., Szőke, É., Sétáló, G., Komoly, S., et al. (2016) · Glia · doi:10.1002/glia.23051 · Cited by 63
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Ghosh, A., Manrique‐Hoyos, N., Voigt, A., Schulz, J. B., Kreutzfeldt, M., Merkler, D., & Simons, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022735 · Cited by 60
Islam, M. S., Tatsumi, K., Okuda, H., Shiosaka, S., & Wanaka, A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.011 · Cited by 59
Furusho, M., Roulois, A., Franklin, R. J. M., & Bansal, R. (2015) · Glia · doi:10.1002/glia.22838 · Cited by 59
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
Brown, R. A., Narayanan, S., & Arnold, D. L. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.06.009 · Cited by 56
Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss
Doan, V., Kleindienst, A. M., McMahon, E. J., Long, B. R., Matsushima, G. K., & Taylor, L. C. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23174 · Cited by 56
Self-citationA revised model for estimating g-ratio from MRI
West, K. L., Kelm, N. D., Carson, R. P., & Does, M. D. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.08.017 · Cited by 54
Targeting human oligodendrocyte progenitors for myelin repair
Dietz, K. C., Polanco, J. J., Pol, S. U., & Sim, F. J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.017 · Cited by 56
Jurevics, H., Hostettler, J., Muse, E. D., Sammond, D. W., Matsushima, G. K., Toews, A. D., & Morell, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00310.x · Cited by 53
Self-citationJung, W., Lee, J., Shin, H., Nam, Y., Zhang, H. G., Oh, S., & Lee, J. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.09.053 · Cited by 48
Zhou, Y.-X., Pannu, R., Le, T. Q., & Armstrong, R. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.004 · Cited by 51
Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination
Seiwa, C., Yamamoto, M., Tanaka, K., Fukutake, M., Ueki, T., Takeda, S., Sakai, R., Ishige, A., Watanabe, K., Akita, M., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21196 · Cited by 50
In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice
Murtie, J. C., Zhou, Y., Le, T. Q., & Armstrong, R. C. (2004) · Glia · doi:10.1002/glia.20142 · Cited by 51
Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes
Palavicini, J. P., Chen, J., Wang, C., Wang, J., Qin, C., Baeuerle, E., Wang, X., Woo, J. A., Kang, D. E., Musi, N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137286 · Cited by 51
Loss of Saltation and Presynaptic Action Potential Failure in Demyelinated Axons
Hamada, M. S., Popovic, M. A., & Kole, M. H. P. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00045 · Cited by 47
Mancini, V. S. B. W., Pasquini, J. M., Correale, J. D., & Pasquini, L. A. (2018) · Glia · doi:10.1002/glia.23540 · Cited by 47
Toxin-Based Models to Investigate Demyelination and Remyelination
McMurran, C. E., Zhao, C., & Franklin, R. J. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9072-6_21 · Cited by 47
Maheshwari, A., Janssens, K., Bogie, J. F. J., den Haute, C. V., Struys, T., Lambrichts, I., Baekelandt, V., Stinissen, P., Hendriks, J. J. A., Slaets, H., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/685317 · Cited by 44
Remyelination assessment by MRI texture analysis in a cuprizone mouse model
Yu, O., Steibel, J., Mauss, Y., Guignard, B., Eclancher, B., Chambron, J., & Grucker, D. (2004) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2004.08.017 · Cited by 43
Tobin, J. E., Xie, M., Le, T. Q., Song, S., & Armstrong, R. C. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31820937e4 · Cited by 42
Orije, J. E. M. J., Kara, F., Guglielmetti, C., Praet, J., der Linden, A. V., Ponsaerts, P., & Verhoye, M. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.04.012 · Cited by 42
Presence and induction of the enzyme NAD(P)H: Quinone oxidoreductase 1 in the central nervous system
Stringer, J. L., Gaikwad, A., Gonzales, B. N., Long, D. J., Marks, L. M., & Jaiswal, A. K. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20048 · Cited by 41
Cuprizone‐induced demyelination in CNP::GFP transgenic mice
Silvestroff, L., Bartucci, S., Soto, E., Gallo, V., Pasquini, J., & Franco, P. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22330 · Cited by 40
Kuypers, N. J., Bankston, A. N., Howard, R. M., Beare, J. E., & Whittemore, S. R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1240-15.2016 · Cited by 43
Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis
Dupree, J. L., Polak, P. E., Hensley, K., Pelligrino, D. A., & Feinstein, D. L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13114 · Cited by 39
How to Use the Cuprizone Model to Study De- and Remyelination
Kipp, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031445 · Cited by 37
“Note that the velocity of remyelination is overestimated in case remyelination is assessed via histochemistry compared with electron-microscopy [26].”
BackgroundMethodInfluentialTakada, N., & Appel, B. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22338 · Cited by 34
Verden, D. R., & Macklin, W. B. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23923 · Cited by 33
Liang, J., Li, N., Zhang, Y., Hou, C., Yang, X., Shimizu, T., Wang, X., Ikenaka, K., Fan, K., & Ma, J. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00152 · Cited by 34
Praet, J., Orije, J. E. M. J., Kara, F., Guglielmetti, C., Santermans, E., Daans, J., Hens, N., Verhoye, M., Berneman, Z. N., Ponsaerts, P., et al. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3277 · Cited by 32
Four in vivo g‐ratio‐weighted imaging methods: Comparability and repeatability at the group level
Ellerbrock, I., & Mohammadi, S. (2017) · Human Brain Mapping · doi:10.1002/hbm.23858 · Cited by 35
Remyelination and recovery of conduction in cat optic nerve after demyelination by pressure
Cottee, L. J., Daniel, C., Loh, W. S., Harrison, B. M., & Burke, W. J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00310-8 · Cited by 30
Metadata
- Authors
- Mason, J. L., Langaman, C., Morell, P., Suzuki, K., & Matsushima, G. K.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Matsushima, G. K.
- ORCID
- Suzuki, K.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2001-02
- Volume
- 27
- Issue
- 1
- Pages
- 50-58
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2156549416
- Cited by
- 172
- References
- 27
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 13 · 2018: 6 · 2017: 8 · 2016: 13 · 2015: 12 · 2014: 9 · 2013: 6 · 2012: 4
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Multiple Sclerosis Society
- National Institutes of Health (RG2754A1, 5r01ns011615-29, 5r01ns037815-05, 5r29ns035372-05)
- National Institute of Neurological Disorders and Stroke (NS 24453, NS37815, R01NS024453, NS-11615, NS-35372)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- cuprizone, demyelination, remyelination, axon diameter, corpus callosum, demyelinating disease, C57BL/6 mice
- MeSH terms
- Amidines, Animals, Axons, Central Nervous System, Chronic Disease, Corpus Callosum, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Fluorescent Dyes, Mice, Inbred C57BL, Microscopy, Electron, Nerve Fibers, Myelinated, Recurrence, Remission, Spontaneous, Cell Size, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review